Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,859 | 13,462 | 27,090 | 15,364 | 50,438 |
| Marketable Securities | 42,553 | 19,782 | 32,932 | 69,488 | 71,308 |
| Receivables | 63,795 | 76,693 | 51,448 | 52,049 | 42,188 |
| Inventories | 42,007 | 44,623 | 52,059 | 54,573 | 52,239 |
| TOTAL | $193,979 | $165,280 | $178,159 | $205,435 | $223,804 |
| Non-Current Assets | |||||
| PPE Net | 20,785 | 20,873 | 21,512 | 22,160 | 22,619 |
| Other Non-Current Assets | 14,435 | 15,071 | 21,207 | 23,356 | 25,529 |
| TOTAL | $35,220 | $35,944 | $42,719 | $45,516 | $48,148 |
| Total Assets | $229,199 | $201,224 | $220,878 | $250,951 | $271,952 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,860 | 1,957 | 4,065 | 3,225 | 6,547 |
| Accrued Expenses | 35,116 | 29,737 | 30,783 | 37,884 | 52,006 |
| TOTAL | $79,745 | $86,722 | $77,900 | $82,355 | $93,876 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,023 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 153,217 | 153,786 | 154,407 | 155,024 | 155,626 |
| TOTAL | $177,240 | $153,786 | $154,407 | $155,024 | $155,626 |
| Total Liabilities | $256,985 | $240,508 | $232,307 | $237,379 | $249,502 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 150,073 | 140,759 | 119,715 | 119,259 | 118,888 |
| Common Shares | 1,411 | 1,199 | 1,193 | 1,191 | 1,188 |
| Retained earnings | -1,895,290 | -1,870,282 | -1,828,223 | -1,795,455 | -1,775,586 |
| Other shareholders' equity | -1 | -6 | 9 | -19 | -57 |
| TOTAL | $-27,786 | $-39,284 | $-11,429 | $13,572 | $22,450 |
| Total Liabilities And Equity | $229,199 | $201,224 | $220,878 | $250,951 | $271,952 |